Determining Unidentified Materials

Determining Unidentified Materials

Our portable tools, such as the FTIR spectrometer ALPHA II and the Raman spectrometer BRAVO, are frequently employed both in forensic laboratories and in on-site inspections to pinpoint unfamiliar compounds. Here, and in the accompanying application note, are instances of our tools in action.

Pharmaceutical Duplication Each nation might have its own official counterfeit drug description, but a comprehensive definition comes from the World Health Organization: “A counterfeit pharmaceutical is one that is purposefully and deceitfully misbranded regarding its identity or origin.” Verifying the genuineness of medicinal products is streamlined using Bruker’s FT-NIR technology. The efficiency and accuracy of this analytical approach bolster efforts by health officials to shield the public from the escalating issue of falsified medicines.

Tainted Medicines The ALPHA FTIR Spectrometer, equipped with an ATR module, is tailor-made for pinpointing both pure and adulterated medications. Automatic scans of the recorded spectra against spectral databases facilitate the drug’s identification. For spectrum matching, the TICTAC database, boasting over 200 spectra of contemporary drugs and “lawful stimulants”, and the ATR-Complete database with over 26,000 spectra spanning numerous substance categories, can be utilized. Coupled with these databases, the ALPHA FTIR spectrometer excels at detecting pure compounds as well as compound mixtures. The OPUS software’s standard search mechanism adeptly identifies the library spectrum most aligned with the acquired spectrum.

Case Study on Identifying Unclassified Compounds via FTIR Spectrometer MOBILE-IR: